Irritable Bowel Syndrome Trial, Recruiting (NCT05972317)

Irritable Bowel Syndrome Trial, Recruiting NCT05972317 Sponsor: Weizmann Institute of Science Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT05972317 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male or female
You are between 18 and 70 years old

Who may not be able to join:

You have taken antibiotics in the 2 months before the trial starts
You have taken probiotic supplements (such as probiotic pills or powders) in the month before the trial starts
You have been diagnosed with type 1 or type 2 diabetes
You are currently pregnant, breastfeeding, or have undergone fertility treatments in the 3 months before the trial starts
You have a long-term (chronic) illness — the study doctor will decide if this applies to you (confirm with trial site)
You have cancer or have recently received cancer treatment
You have a psychiatric (mental health) disorder — the study doctor will decide if this applies to you (confirm with trial site)
You have an inflammatory bowel disease, such as Crohn's disease or ulcerative colitis
You have issues with alcohol or substance misuse
Your BMI (a measure of body weight relative to height) is above 35

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eran Elinav, Prof, Weizmann Institute of Science

Phone: +97289529173

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05972317

Sponsor: Weizmann Institute of Science

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: +97289529173

More information: https://clinicaltrials.gov/study/NCT05972317

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male or female
You are between 18 and 70 years old

Who may not be able to join:

You have taken antibiotics in the 2 months before the trial starts
You have taken probiotic supplements (such as probiotic pills or powders) in the month before the trial starts
You have been diagnosed with type 1 or type 2 diabetes
You are currently pregnant, breastfeeding, or have undergone fertility treatments in the 3 months before the trial starts
You have a long-term (chronic) illness — the study doctor will decide if this applies to you (confirm with trial site)
You have cancer or have recently received cancer treatment
You have a psychiatric (mental health) disorder — the study doctor will decide if this applies to you (confirm with trial site)
You have an inflammatory bowel disease, such as Crohn's disease or ulcerative colitis
You have issues with alcohol or substance misuse
Your BMI (a measure of body weight relative to height) is above 35

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weizmann Institute of Science

Registry

ClinicalTrials.gov

Start date

11 May 2026

Est. completion

1 January 2028

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

IBS-SSS - irritable bowel syndrome severity score system questionnaire; IBS-QOL questionnaire - irritable bowel syndrome quality of life questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov